earnings call
Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Aurinia Pharmaceuticals Inc (AUPH) SEC filings
Aurinia Pharmaceuticals Inc (AUPH) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported AUPH revenue for 2026-06-30 was $83.2M. Net income was $37.4M. Revenue was up 7.1% from 2026-03-31 to 2026-06-30. AUPH currently screens at market cap $1.03B and trailing P/E 7.2. The AUPH filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Aurinia Pharmaceuticals Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsearnings call
Event insights for AUPH — what management said, what changed, and why it matters.
No cached SEC filings for AUPH yet. When an 8-K lands, this page will list it.
These filings as JSON? API free 100/dayAUPH SEC filings FAQ
What events are listed on the AUPH SEC page?
Cached event headlines on this Aurinia Pharmaceuticals Inc (AUPH) SEC page: "AUPH earnings". Events: https://lician.com/sec/auph
What is AUPH's P/E ratio?
Aurinia Pharmaceuticals Inc (AUPH) trailing P/E is 7.21 on the latest cached fundamentals snapshot.
What are AUPH's latest revenue and net income?
Latest cached Aurinia Pharmaceuticals Inc (AUPH) revenue for Jun 30, 2026 was $83.2M. Net income was $37.4M. Statements: https://lician.com/financials/auph